| JXHL1400038 | 糠酸氟替卡松维兰特罗粉雾剂(Ⅲ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs | Import Drug Application | 2014-02-22 | Glaxo Group Limited | Glaxo Group Ltd | Certificate Issued | 2016-09-26 | view |
| JXHS1600080 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Import Drug Application | 2017-01-22 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd | Certificate Issued | 2018-08-07 | view |
| JYHB1900019 | 糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅲ） | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2019-01-09 | | Glaxo Operations UK Ltd;Glaxo Group Ltd | Filed | 2019-01-11 | view |
| JYHB1900924 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs | Supplementary Application | 2019-07-29 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd | Filed | 2019-08-08 | view |
| JYHB2100015 | 糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅲ） | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-01-08 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | Certificate Issued | 2021-02-01 | view |
| JYHB2100113 | 糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅲ） | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-02-03 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd | In Review | 2021-02-03 | view |
| JYHB2101626 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | Supplementary Application | 2021-12-30 | | Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | | | view |
| JYHZ2300034 | 糠酸氟替卡松维兰特罗吸入粉雾剂(Ⅲ) | fluticasone furoate;vilanterol | Powder for inhalation | Chemical Drugs(5.1) | License Renew | 2023-01-18 | | GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd | | | view |
